The AUD/USD exchange rate rose to 0.6587 on July 2, 2025, up 0.12% from the previous session. Over the past month, the Australian Dollar has strengthened 1.93%, but it's down by 1.86% over the last 12 months. Australian Dollar - values, historical data, forecasts and news - updated on July of 2025.

The exchange rate from Australian dollar to U.S. dollar fluctuated in recent years, but reached its highest level observed since January 2018 in early 2021. By May 2, 2025, the exchange rate was valued at roughly 0.64 U.S. dollars. The average (standardized) measure is based on the calculation of many observations throughout the period in question. It is therefore different than an annual measure at point in time, which reflects concrete values as of end of the year.

The Euro to Australian exchange rate history reveals a peak in March 2020, before declining well until mid 2022. Exchange rates fluctuate against each other constantly. As of May 2, 2025, the exchange rate was avalued at 1.77 Australian dollars per euro. The rate in which one currency performs against another depends on the demand that it generates at any given time. Exchange rates are affected by several factors including international trade, tourism and geopolitical tensions.Euro gains strength against the Brexit PoundOne good example of geopolitical risks having a negative effect on the strength of a currency is to look at the British Pound post Brexit referendum. The average annual exchange rate of the Euro to GBP increased significantly between 2015 and 2018.The Euro vs the worldSince 2016, the euro has performed well against several other currencies. The Euro to U.S dollar had seen its annual average exchange rate increase by .07 between 2016 and 2018, after slightly decreasing in 2019. Against the Indian Rupee, the Euro had performed even better, with the average annual exchange rate equaling 78.84 in 2019.

Graph and download economic data for U.S. Dollars to Australian Dollar Spot Exchange Rate (DEXUSAL) from 1971-01-04 to 2025-06-27 about Australia, exchange rate, currency, rate, and USA.

Prices for SGDAUD Singapore Dollar Australian Dollar including live quotes, historical charts and news. SGDAUD Singapore Dollar Australian Dollar was last updated by Trading Economics this July 3 of 2025.

External Debt: Assets: Up to 90 Days: Australian Dollar data was reported at -71,321.000 AUD mn in Dec 2024. This records an increase from the previous number of -82,663.000 AUD mn for Sep 2024. External Debt: Assets: Up to 90 Days: Australian Dollar data is updated quarterly, averaging -48,265.000 AUD mn from Sep 1996 (Median) to Dec 2024, with 114 observations. The data reached an all-time high of -6,546.000 AUD mn in Dec 1996 and a record low of -133,858.000 AUD mn in Sep 2022. External Debt: Assets: Up to 90 Days: Australian Dollar data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.JB041: BPM6: External Debt: Assets and Liabilities: by Residual Maturity and Currency.

External Debt: Liabilities: Up to 90 Days: United Kingdom Pound data was reported at 17,131.000 AUD mn in Dec 2024. This records an increase from the previous number of 15,960.000 AUD mn for Sep 2024. External Debt: Liabilities: Up to 90 Days: United Kingdom Pound data is updated quarterly, averaging 14,339.500 AUD mn from Sep 1996 (Median) to Dec 2024, with 114 observations. The data reached an all-time high of 41,457.000 AUD mn in Jun 2009 and a record low of 1,280.000 AUD mn in Sep 1996. External Debt: Liabilities: Up to 90 Days: United Kingdom Pound data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.JB041: BPM6: External Debt: Assets and Liabilities: by Residual Maturity and Currency.

Prices for AUDMYR Australian Dollar Malaysian Ringgit including live quotes, historical charts and news. AUDMYR Australian Dollar Malaysian Ringgit was last updated by Trading Economics this July 2 of 2025.

External Debt: Liabilities: Up to 90 Days: Australian Dollar data was reported at 242,295.000 AUD mn in Dec 2024. This records a decrease from the previous number of 253,802.000 AUD mn for Sep 2024. External Debt: Liabilities: Up to 90 Days: Australian Dollar data is updated quarterly, averaging 113,231.000 AUD mn from Sep 1996 (Median) to Dec 2024, with 114 observations. The data reached an all-time high of 372,177.000 AUD mn in Sep 2022 and a record low of 23,721.000 AUD mn in Sep 1996. External Debt: Liabilities: Up to 90 Days: Australian Dollar data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.JB041: BPM6: External Debt: Assets and Liabilities: by Residual Maturity and Currency.

A graphic that displays the dollar performance against other currencies reveals that economic developments had mixed results on currency exchanges. The third quarter of 2023 marked a period of disinflation in the euro area, while China's projected growth was projected to go up. The United States economy was said to have a relatively strong performance in Q3 2023, although growing capital market interest rate and the resumption of student loan repayments might dampen this growth at the end of 2023. A relatively weak Japanese yen Q3 2023 saw pressure from investors towards Japanese authorities on how they would respond to the situation surrounding the Japanese yen. The USD/JPY rate was close to ***, whereas analysts suspected it should be around ** given the country's purchase power parity. The main reason for this disparity is said to be the differences in central bank interest rates between the United States, the euro area, and Japan. Any future aggressive changes from, especially the U.S. Fed might lower those differences. Financial markets responded somewhat disappoint when Japan did not announce major plans to tackle the situation. Potential rent decreases in 2024 Central bank rates peak in 2023, although it is expected that some of these will decline in early 2024. That said, analysts expect overall policies will remain restrictive. For example, the Bank of England's interest rate remained unchanged at **** percent in Q3 2023. It is believed the United Kingdom's central bank will ease its interest rate in 2024 but less than either the U.S. Fed or the European Central Bank. This should be a positive development for the pound compared to either the euro or the dollar.

Prices for AUDPKR Australian Dollar Pakistani Rupee including live quotes, historical charts and news. AUDPKR Australian Dollar Pakistani Rupee was last updated by Trading Economics this July 3 of 2025.

Australia External Debt: Assets: Up to 90 Days: United Kingdom Pound data was reported at -20,325.000 AUD mn in Dec 2024. This records an increase from the previous number of -22,962.000 AUD mn for Sep 2024. Australia External Debt: Assets: Up to 90 Days: United Kingdom Pound data is updated quarterly, averaging -12,163.500 AUD mn from Sep 1996 (Median) to Dec 2024, with 114 observations. The data reached an all-time high of -606.000 AUD mn in Dec 1997 and a record low of -36,009.000 AUD mn in Dec 2021. Australia External Debt: Assets: Up to 90 Days: United Kingdom Pound data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.JB041: BPM6: External Debt: Assets and Liabilities: by Residual Maturity and Currency.

The global market for Alcohol Use Disorder (AUD) treatment is experiencing robust growth, projected at a Compound Annual Growth Rate (CAGR) of 6.5% from 2025 to 2033. In 2025, the market size is estimated at $712 million. This expansion is driven by several factors, including the rising prevalence of AUD worldwide, increased awareness and reduced stigma surrounding the disorder, and the development of innovative treatment modalities. The rising number of individuals seeking professional help, coupled with the increased availability of effective medications and therapies, contributes significantly to market growth. Furthermore, the integration of multidisciplinary treatment approaches, combining medication, therapy, and other support systems, is enhancing treatment efficacy and patient outcomes, further fueling market expansion. The market is segmented by application (hospital, clinic) and treatment type (medication, therapy, multidisciplinary treatment), offering various avenues for growth. North America currently holds a substantial market share due to advanced healthcare infrastructure and high awareness levels. However, significant growth potential exists in other regions, particularly in Asia Pacific, driven by increasing disposable incomes and rising healthcare expenditure. The market faces some challenges. High treatment costs and limited access to care in low- and middle-income countries remain significant restraints. Furthermore, relapse rates continue to be a concern, highlighting the need for ongoing support and improved treatment adherence strategies. However, ongoing research and development in AUD treatment, including the exploration of novel pharmacological agents and therapeutic techniques, are expected to address these challenges and drive future growth. Leading companies in the AUD treatment market, including Alkermes Plc., Teva Pharmaceutical Industries Ltd., and others, are actively engaged in developing and marketing innovative treatments, thereby contributing to the market's expansion and improving patient outcomes. The market's future prospects remain positive, driven by continued technological advances, increasing public health initiatives, and a growing recognition of the need for comprehensive and accessible AUD treatment.

The global market for Alcohol Use Disorder (AUD) treatment is experiencing robust growth, projected to reach a value of $687.3 million in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 6.2% from 2019 to 2033. This expansion reflects a rising awareness of AUD as a significant public health concern and increasing demand for effective treatment options. Several factors drive market growth, including the growing prevalence of AUD worldwide, the development and approval of novel therapies targeting specific AUD mechanisms, increased access to telehealth services expanding treatment reach, and growing insurance coverage for AUD treatments. Furthermore, ongoing research into personalized medicine approaches, focusing on tailoring treatment plans to individual patient characteristics and genetic predispositions, promises further market expansion. The market's segmentation likely reflects various therapeutic approaches (pharmacological, behavioral, combined therapies), and differing levels of care (inpatient, outpatient, etc.), with potentially substantial variations in market share among these segments. The key players – Alkermes Plc., Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals Inc., Addex Therapeutics Ltd., Kinnov Therapeutics, Opiant Pharmaceuticals, Omeros Corporation, GlaxoSmithKline plc, and Merck & Co. Inc. – are actively engaged in research, development, and commercialization efforts within this dynamic space, driving innovation and competition. The significant market growth in AUD treatment is fueled by the increasing recognition of the devastating impact of alcohol abuse on individuals, families, and society as a whole. Governments worldwide are investing more in public health initiatives, aiming to increase awareness and improve access to effective treatments. This increased societal investment, coupled with advancements in understanding the neurobiological underpinnings of AUD and the development of more targeted and effective treatments, is expected to sustain the market's strong growth trajectory throughout the forecast period (2025-2033). While certain constraints such as stigma associated with AUD treatment and the complexities of managing chronic relapsing conditions exist, ongoing efforts to reduce stigma and improve treatment accessibility are likely to mitigate these limitations, contributing to the continued expansion of this crucial market.

Australia External Debt: Assets: Up to 90 Days: Other data was reported at -471,968.000 AUD mn in Dec 2024. This records a decrease from the previous number of -55,800.000 AUD mn for Sep 2024. Australia External Debt: Assets: Up to 90 Days: Other data is updated quarterly, averaging -24,094.000 AUD mn from Sep 1996 (Median) to Dec 2024, with 114 observations. The data reached an all-time high of 45,301.000 AUD mn in Jun 2024 and a record low of -471,968.000 AUD mn in Dec 2024. Australia External Debt: Assets: Up to 90 Days: Other data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.JB041: BPM6: External Debt: Assets and Liabilities: by Residual Maturity and Currency.

These data are derived from returns submitted to the Australian Prudential Regulation Authority (APRA) by banks authorised under the Banking Act 1959. APRA assumed responsibility for the supervision …Show full descriptionThese data are derived from returns submitted to the Australian Prudential Regulation Authority (APRA) by banks authorised under the Banking Act 1959. APRA assumed responsibility for the supervision and regulation of banks on 1 July 1998. Data prior to that date were submitted to the RBA. Up to and including June 2000, data are averages of weekly (Wednesday) figures. From July 2000, data are for the last business day of every month. Up to and including March 2002, banks submitted Form D (Statement of Liabilities and Assets on the Australian Books). In March 2002, APRA implemented new reporting forms for banks. The data, dating from April 2002, are derived from ARF 320.0 Statement of Financial Position (Domestic Books). ARF 320.0 covers the domestic books of the licensed bank and is an unconsolidated report of the Australian bank’s operations/transactions that are booked or recorded inside Australia (with Australian residents and non-residents). ARF 320.0 does not consolidate Australian and offshore-controlled entities (thus offshore branches of the Australian bank are excluded). ARF 320.0 includes transactions of Australian-based offshore banking units of the licensed ADI but excludes transactions of overseas-based offshore banking units. An Australian ‘resident’ is any individual, business or other organisation domiciled in Australia. Australian branches and subsidiaries of foreign businesses are regarded as Australian residents. A ‘non-resident’ is any individual, business or other organisation domiciled overseas. Foreign branches and subsidiaries of Australian businesses are regarded as non-residents. ‘Resident liabilities – deposits’ include: transaction and non-transaction deposit accounts; and certificates of deposit. From April 2002, this item includes both Australian dollar- and foreign currency-denominated (AUD equivalent) deposits. Prior to that date foreign currency-denominated (AUD equivalent) deposits are included in ‘resident liabilities – other liabilities’. Certificates of deposit relate to both residents and non-residents. ‘Resident liabilities – bill acceptances’ refers to liabilities arising from undertakings by banks to pay bills of exchange drawn on customers. From April 2002, this item includes both Australian dollar- and foreign currency-denominated (AUD equivalent) bill acceptances. Prior to that date foreign currency-denominated (AUD equivalent) bill acceptances are included in ‘resident liabilities – other liabilities’. Prior to April 2002, ‘resident liabilities – other borrowings’ refers to Australian dollar-denominated items only and includes: balances (other than deposits) to overseas banks not authorised in Australia; issues of term subordinated debt; and loan capital and similar instruments. From April 2002, this item includes: Australian dollar- and foreign currency-denominated (AUD equivalent) other borrowings; securities sold under agreements to repurchase; promissory notes and commercial paper; other short-term debt securities; bonds; notes; and long-term borrowings. ‘Resident liabilities – other liabilities’ refers to all other resident liabilities not included in the above items. Prior to April 2002, this item includes: all provision accounts other than those relating to bad and doubtful debts; accounts payable and prepayments received; gold bullion borrowings that are repayable in physical gold; credit balances resulting from netting of all deferred tax liabilities and tax benefit accounts; cheques drawn by a bank on itself but not yet presented; and all other resident liabilities on banks’ Australian books other than retained earnings and shareholders’ funds, accrued interest not yet payable and inter-branch accounts. From April 2002, this item includes: liabilities due to clearing houses and due to financial institutions in relation to the payments system; income tax liabilities; provisions for dividends, employee entitlements, non-lending losses, restructuring costs and other; creditor and related liabilities; and loan capital and hybrid securities. Note that, from April 2002, this item also includes: accrued interest not yet payable; inter-branch transfers; and unrealised losses on trading derivatives – prior to that date, these were excluded. ‘Resident liabilities – total’ refers to total liabilities on the Australian books of banks that are due to residents, and is the sum of the above items. ‘Resident liabilities – of which: denominated in foreign currency’ refers to the Australian dollar equivalent of ‘resident liabilities – total’ on the Australian books of banks that are denominated in foreign currency. ‘Non-resident liabilities – total’ refers to total liabilities on the Australian books of banks that are due to non-residents, though from April 2002, this series excludes the total amount due to banks’ overseas operations, which have been separately identified on the new reporting form. ’Non-resident liabilities – of which: denominated in foreign currency’ refers to the Australian dollar equivalent of ‘non-resident liabilities – total’ on the Australian books of banks that are denominated in foreign currency. ‘Total liabilities’ is the sum of ‘resident liabilities – total’ and ‘non-resident liabilities – total’. From April 2002, this item also includes the ‘amount due to overseas operations’, which is identified separately from ‘resident liabilities – total’ and ‘non-resident liabilities – total’. The ‘amount due to overseas operations’ refers to domestic book on-balance sheet liabilities due to the overseas operations of banks that have not been included in the above items

The Online Book Sales industry has faced mixed operating conditions. While an appreciating Australian dollar has made international book sites more price competitive, an overarching shift towards online shopping has driven local demand. Enhanced website design, improved navigation, and better online security and payment options have collectively boosted consumer confidence in online purchases. Industry revenue is expected to expand at an annualised 4.0% to $593.4 million over the five years through 2024-25. This trend includes a hike of 5.2% in the current year, as rising internet subscriber numbers, an upswing in consumer sentiment and an income hike encourage continued online spending. The Online Book Sales industry has experienced notable expansion, driven by the increased convenience and cost savings of online shopping. Books, being low-value and cost-efficient for delivery, have thrived in this environment. The surge in demand during the pandemic exemplified this trend, with lockdowns pushing consumers towards online purchases for entertainment. However, industry competition intensified as more entrants sought to capture market share. Traditional bookstores have also pivoted to online platforms, crowding the digital space. Legislative changes like Australia's GST adjustments since July 2018 have given local online stores a competitive edge. Yet, international giants continue to pose a challenge because of their extensive reach, economies of scale and an appreciating Australian dollar. Going forwards, revenue across the Online Book Sales industry is set to expand by an annualised 4.2% through the end of 2029-30 to $727.7 million. Rising internet subscriber numbers, stronger income growth, improved consumer sentiment, and enhanced online security and payment systems will provide opportunities for revenue to expand. Yet, greater competition from new entrants and established sites like Amazon and Booktopia will hamper profit growth. Digital formats, especially ebooks, will remain crucial, driven by ease of access and lower costs. Technological advancements will continue to enhance the quality and functionality of ebooks and ereaders, causing this segment to strengthen, notably within educational publishing, as schools and students seek more affordable and portable options.

The global acamprosate market, valued at $34 million in 2025, exhibits a steady Compound Annual Growth Rate (CAGR) of 2.3%. This growth is driven by a rising prevalence of alcohol use disorder (AUD), coupled with increased awareness and acceptance of medication-assisted treatment (MAT) for AUD management. The market segmentation reveals a preference for 333 mg delayed-release tablets, reflecting a focus on efficacy and convenience. Hospital and clinic applications dominate the market share, highlighting the importance of professional healthcare settings in AUD treatment. Key players, including Merck Group, Zydus Pharmaceuticals, Mylan, Teva, and Glenmark Pharmaceuticals, are shaping the competitive landscape through innovation and expansion efforts. Geographic distribution sees North America and Europe as leading markets, reflecting higher healthcare spending and greater awareness of AUD treatment options. However, emerging markets in Asia-Pacific show significant growth potential due to expanding healthcare infrastructure and rising AUD incidence. Factors such as stringent regulatory approvals and potential side effects of acamprosate pose challenges to market expansion. Future growth hinges on several factors. Continued research and development into improved formulations and delivery methods could boost market adoption. Furthermore, increased public awareness campaigns and improved access to affordable healthcare in developing countries will likely stimulate demand. The market is also expected to see the introduction of new therapies and formulations, enhancing treatment effectiveness and patient compliance. Competition among pharmaceutical companies will drive innovation and potentially lower prices, making acamprosate more accessible to a wider patient population. Successful marketing strategies focused on educating healthcare professionals and patients about the benefits of acamprosate will be crucial for continued market expansion.

The cohort studies are treatment cohorts which assessed the clinical, social and economic outcomes of patients who have received a diagnosis of depression, alcohol use disorder (AUD), psychosis or epilepsy. In some countries a control group (patients who screen positive for a disorder but were undiagnosed by a clinician) were also followed up. Key research themes included social, health and economic outcomes, equity of access, and stigma, discrimination, adherence and retention in care. After the baseline data collection, patients were followed-up after 3 or 6 months (mid-line visit), and again 12 months after the baseline (end-line visit). A detailed description of the cohort methods has been published in BMC Psychiatry (see link on references).Below is a brief overview of the design, recruitment and data collection methods. If you wish to access the cohort dataset, please complete an expression of interest form (see link on references).

The Australia oat milk market size reached AUD 196.0 Million in 2024. Looking forward, IMARC Group expects the market to reach AUD 1,092.8 Million by 2033, exhibiting a growth rate (CAGR) of 19.99% during 2025-2033. The expanding vegan and vegetarian population, rising prevalence of lactose intolerance, increasing health consciousness, and the launch of oat milk in unique flavors across the country represent some of the key factors driving the market.

IMARC Group provides an analysis of the key trends in each segment of the Australia oat milk market, along with forecasts at the regional and country levels from 2025-2033. Our report has categorized the market based on source, flavor, and packaging form.